MD3906F1 - Method for treating the neurotic enuresis to children - Google Patents

Method for treating the neurotic enuresis to children Download PDF

Info

Publication number
MD3906F1
MD3906F1 MDA20080098A MD20080098A MD3906F1 MD 3906 F1 MD3906 F1 MD 3906F1 MD A20080098 A MDA20080098 A MD A20080098A MD 20080098 A MD20080098 A MD 20080098A MD 3906 F1 MD3906 F1 MD 3906F1
Authority
MD
Moldova
Prior art keywords
months
homaccord
urination
pill
neurotic
Prior art date
Application number
MDA20080098A
Other languages
Romanian (ro)
Other versions
MD3906G2 (en
Inventor
Svetlana Hadjiu
Original Assignee
Svetlana Hadjiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Svetlana Hadjiu filed Critical Svetlana Hadjiu
Priority to MDA20080098A priority Critical patent/MD3906G2/en
Publication of MD3906F1 publication Critical patent/MD3906F1/en
Publication of MD3906G2 publication Critical patent/MD3906G2/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, si anume la neurologie, pediatrie si este destinata pentru tratamentul enurezisului nevrotic la copii. Metoda, conform inventiei, consta in aceea ca pacientului i se administreaza per os preparatele Berberis-Homaccord si Sabal-Homaccord timp de 3 luni de 3 ori pe zi cate 3...7 picaturi, Reneel timp de 1…2 luni cate 1 pastila de 3 ori pe zi, Nervoheel timp de 2…3 luni cate 1 pastila de 3 ori pe zi si subcutanat Cerebrum Compositum N de 2 ori pe saptamana cate 1,1...2,2 ml, Tonico-Injeel cate 0,7....1,1 ml, Solidago Compositum S si Traumeel S cate 1,1…2,2 ml o data pe saptamana in decurs de 5…10 saptamani in regiunea punctelor biologic active E 36; IG 3; G 14; C 5; VB 39; TR 5, 10; P10; V21, 22, 28, 31, 40, 62; R2, 7; F2, 3, 8; VC3, 4, 6; VG 2, 4, totodata in fiecare punct biologic activ se administreaza un singur preparat medicamentos din cele mentionate, fiecare preparat se administreaza in 3…5 puncte. Se efectueaza masaj general relaxant, se limiteaza folosirea lichidelor dupa ora 18.00-19.00, se trezeste copilul pana la orele 1.00-2.00 pentru mictiune, se folosesc semnale sonore pentru formarea reflexului conditionat la mictiune, se respecta dieta cu excluderea gustarilor sarate seara. Seria de tratament se repeta de 2…3 ori peste 2…4 luni.The invention relates to medicine, namely neurology, pediatrics and is intended for the treatment of neurotic enuresis in children. The method, according to the invention, is that the patient is given by bone the Berberis-Homaccord and Sabal-Homaccord preparations for 3 months 3 times a day for 3 to 7 drops, Reneel for 1 ... 2 months for 1 pill 3 times daily, Nervoheel for 2 ... 3 months each 1 pill 3 times daily and subcutaneously Cerebrum Compositum N 2 times a week each 1.1 ... 2.2 ml, Tonico-Injeel 0.7 .... 1.1 ml, Solidago Compositum S and Traumeel S each 1.1 ... 2.2 ml once a week within 5 ... 10 weeks in the region of biologically active points E 36; IG 3; G 14; C 5; VB 39; TR 5, 10; P10; V21, 22, 28, 31, 40, 62; R2, 7; F2, 3, 8; VC3, 4, 6; VG 2, 4, at the same time in each biologically active point, a single drug preparation of the mentioned ones is administered, each preparation is administered in 3… 5 points. There is a general relaxing massage, the use of liquids is limited after 18.00-19.00, the child wakes up until 1.00-2.00 for the urination, sound signals are used to form the conditioned reflex at the urination, the diet is respected with the exclusion of salted snacks in the evening. The treatment series is repeated 2 ... 3 times over 2 ... 4 months.

MDA20080098A 2008-03-31 2008-03-31 Method for treating the neurotic enuresis to children MD3906G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080098A MD3906G2 (en) 2008-03-31 2008-03-31 Method for treating the neurotic enuresis to children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080098A MD3906G2 (en) 2008-03-31 2008-03-31 Method for treating the neurotic enuresis to children

Publications (2)

Publication Number Publication Date
MD3906F1 true MD3906F1 (en) 2009-05-31
MD3906G2 MD3906G2 (en) 2010-01-31

Family

ID=40901751

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080098A MD3906G2 (en) 2008-03-31 2008-03-31 Method for treating the neurotic enuresis to children

Country Status (1)

Country Link
MD (1) MD3906G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD49Z (en) * 2009-04-10 2010-04-30 Дмитрий СКУРТУ Massage device
MD81Z (en) * 2009-05-13 2010-05-31 Дмитрий СКУРТУ Chair-trainer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2618085C2 (en) * 2015-10-13 2017-05-02 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский государственный университет физической культуры, спорта, молодежи и туризма (ГЦОЛИФК)" (РГУФКСМиТ) Method for pre-start neuroes correction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2070027C1 (en) * 1992-04-13 1996-12-10 Игорь Анатольевич Витовский Method for treatment of enuresis
RU2156145C1 (en) * 1999-11-15 2000-09-20 Небера Сергей Анатольевич Method for treating the cases of enuresis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD49Z (en) * 2009-04-10 2010-04-30 Дмитрий СКУРТУ Massage device
MD81Z (en) * 2009-05-13 2010-05-31 Дмитрий СКУРТУ Chair-trainer

Also Published As

Publication number Publication date
MD3906G2 (en) 2010-01-31

Similar Documents

Publication Publication Date Title
Randhawa Cow urine distillate as bioenhancer
MX349090B (en) Modular spacer device for the treatment of infections of the prosthesis of the human limbs.
BR112015018252A2 (en) stable fixed-dose aqueous pharmaceutical composition for nasal administration to a human, stable fixed-dose aqueous pharmaceutical composition for nasal administration for a human, stable suspension suitable for nasal administration to a human, method for treating rhinitis in a human human in need thereof, use of the pharmaceutical composition for nasal administration, method for releasing a pharmaceutical composition and kit
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EA201591529A1 (en) TREATMENT OF CHILDREN'S DEFICIENCY OF GROWTH HORMONE BY HUMAN ANALOGUES OF HORMONE GROWTH
BR112014018485A8 (en) USE OF LAQUINIMOD TO TREAT PATIENTS WITH CROHN'S DISEASE WHO HAVE FAILED FIRST LINE ANTI-TNF THERAPY
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
RU2016147048A (en) ANTI-MICROBIAL IMMUNOMODULATION
MD3906F1 (en) Method for treating the neurotic enuresis to children
AR072951A1 (en) USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
JOP20190019A1 (en) Pharmaceutical Formula for Treatment of Growth Hormone Deficiency Contains Human Growth Hormone (hGH) Fusion Protein
CN105477218A (en) Traditional Chinese medicine composition for preventing influenza and application thereof
Kelleher et al. Absorption, distribution, metabolism, and elimination (ADME) of umeclidinium (UMEC) in healthy adults
MD3803F1 (en) Method of treating hyperkinesia of children
NZ703729A (en) Combinations with a backbone-cyclized peptide
Wang et al. Study on the compliance and economic cost of rabies vaccination
Kremer et al. SAT0103 Lithe: Tocilizumab (TCZ) Inhibits Radiographic Progression and Improves Physical Function in Patients (PTS) With Rheumatoid Arthritis (RA) at 5 Years With Maintenance of Clinical Efficacy Over Time
CN101549049B (en) Chinese medicinal combination for treating acute nephritis and chronic nephritis
Matsuo et al. Correction to: attenuation of cortical activity triggering descending pain inhibition in chronic low back pain patients: a functional magnetic resonance imaging study
CN101647803B (en) External-use medicine for treating burns
RU2008107113A (en) MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE
IL310517A (en) Bupivacaine-collagen drug delivery implant and methods for its preparation and use
NZ773583A (en) Methods of treating psoriasis
CN103952268A (en) Pseudo-ginseng health care wine

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees